Disclosed are compounds of formula I that inhibit histone deacetylase (HDAC) enzymatic activity, pharmaceutical compositions comprising such compounds, as well as methods to treat conditions, particularly proliferative conditions, mediated at least in part by HDAC, wherein A, W, W
1
, W
2
, Ar
2
, and G are described herein.
Practical syntheses of hexahydroazepino[4,5-b]- and hexahydroazocino[4,5-b]indoles
作者:Khalid Diker、Michèle Döé de Maindreville、Jean Lévy
DOI:10.1016/0040-4039(95)00530-p
日期:1995.5
Catalytic hydrogenation (Pd·C) of 2-(2-benzylaminoethyl)-3-cyanomethyl indoles gave hexahydroazepino[4,5-b]indoles in good yields. 2-(2-Benzylaminoethyl)-3 cyanoethyl indoles were cyclized to hexahydroazocino[4,5-b]indoles under identical conditions.